<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">Cell cycle is an extremely controlled process involving complex cascade of events and dysregulation of this control leads to the development of cancer (
 <xref rid="bib8" ref-type="bibr">Bailon-Moscoso et al., 2017</xref>). Cell cycle progression is under control of regulatory proteins such as cyclins, CDKs (cyclin-dependent kinases) and tumor suppressor genes such as p53 (
 <xref rid="bib70" ref-type="bibr">Sanchez and Dynlacht, 2005</xref>; 
 <xref rid="bib85" ref-type="bibr">Wang et al., 2015</xref>). Nature-derived bioactive compounds have promising ability to modulate the expression of various cyclins, CDKs and CDK inhibitors (CKIs), thus, halting proliferation in human cancers (
 <xref rid="bib46" ref-type="bibr">Johansson and Persson, 2008</xref>).
</p>
